Proenkephalin Compared to Conventional Methods to Assess Kidney Function in Critically Ill Sepsis Patients.
Journal
Shock (Augusta, Ga.)
ISSN: 1540-0514
Titre abrégé: Shock
Pays: United States
ID NLM: 9421564
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
pubmed:
25
1
2020
medline:
20
7
2021
entrez:
25
1
2020
Statut:
ppublish
Résumé
The assessment of renal function in clinical practice remains challenging. Using creatinine to assess the glomerular filtration rate (GFR) is notoriously inaccurate, and determination of the true GFR, e.g., using inulin or iohexol, is laborious and not feasible in daily practice. Proenkephalin (PENK) is a novel candidate biomarker for kidney function that is filtrated in the glomerulus, has shown to represent steady-state GFR in patients with different severities of renal insufficiency. In this pilot study in non-steady-state critically ill patients, we compared plasma PENK concentrations with creatinine-based GFR assessments and validated both against the "true GFR" measured using a gold standard method: iohexol plasma clearance. Twenty-three critically ill patients with septic shock were included. Kidney function was determined using the Modification of Diet in Renal Disease formula (eGFRMDRD), Endogenous Creatinine Clearance (GFRECC), and iohexol plasma clearance (GFRiohexol) during a 6-h window. Plasma PENK concentrations were measured using the penKid immunoassay. The eGFRMDRD and GFRECC correlated with the GFRiohexol (R = 0.82, P < 0.0001 and R = 0.82, P < 0.0001 respectively); however, bias and variability were considerable: the eGFRMDRD overestimated the true GFR with 31 ± 35% (95% limits of agreement: -37% to 100%) and the GFRECC with 37 ± 49% (95% limits of agreement: -59% to 133%). Plasma PENK concentrations showed a very strong inverse correlation with the GFRiohexol (R = 0.90, P < 0.0001) which tended to be better compared with the correlation of eGFRMDRD (P = 0.06) and GFRECC (P = 0.08) with the GFRiohexol. In this pilot study in non-steady-state critically ill sepsis patients, GFR appears to be more accurately reflected by plasma PENK concentrations compared to conventional creatinine-based methods. Therefore, PENK holds promise as an accurate and feasible biomarker to determine kidney function during non-steady-state conditions in the critically ill.
Sections du résumé
BACKGROUND
The assessment of renal function in clinical practice remains challenging. Using creatinine to assess the glomerular filtration rate (GFR) is notoriously inaccurate, and determination of the true GFR, e.g., using inulin or iohexol, is laborious and not feasible in daily practice. Proenkephalin (PENK) is a novel candidate biomarker for kidney function that is filtrated in the glomerulus, has shown to represent steady-state GFR in patients with different severities of renal insufficiency. In this pilot study in non-steady-state critically ill patients, we compared plasma PENK concentrations with creatinine-based GFR assessments and validated both against the "true GFR" measured using a gold standard method: iohexol plasma clearance.
METHODS
Twenty-three critically ill patients with septic shock were included. Kidney function was determined using the Modification of Diet in Renal Disease formula (eGFRMDRD), Endogenous Creatinine Clearance (GFRECC), and iohexol plasma clearance (GFRiohexol) during a 6-h window. Plasma PENK concentrations were measured using the penKid immunoassay.
RESULTS
The eGFRMDRD and GFRECC correlated with the GFRiohexol (R = 0.82, P < 0.0001 and R = 0.82, P < 0.0001 respectively); however, bias and variability were considerable: the eGFRMDRD overestimated the true GFR with 31 ± 35% (95% limits of agreement: -37% to 100%) and the GFRECC with 37 ± 49% (95% limits of agreement: -59% to 133%). Plasma PENK concentrations showed a very strong inverse correlation with the GFRiohexol (R = 0.90, P < 0.0001) which tended to be better compared with the correlation of eGFRMDRD (P = 0.06) and GFRECC (P = 0.08) with the GFRiohexol.
CONCLUSIONS
In this pilot study in non-steady-state critically ill sepsis patients, GFR appears to be more accurately reflected by plasma PENK concentrations compared to conventional creatinine-based methods. Therefore, PENK holds promise as an accurate and feasible biomarker to determine kidney function during non-steady-state conditions in the critically ill.
Identifiants
pubmed: 31977957
doi: 10.1097/SHK.0000000000001510
pmc: PMC7458088
pii: 00024382-202009000-00006
doi:
Substances chimiques
Enkephalins
0
Protein Precursors
0
proenkephalin
0
Iohexol
4419T9MX03
Inulin
9005-80-5
preproenkephalin
93443-35-7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
308-314Références
J Am Coll Cardiol. 2017 Jan 3;69(1):56-69
pubmed: 28057251
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Ann Lab Med. 2017 Sep;37(5):388-397
pubmed: 28643487
Am J Kidney Dis. 2016 Aug;68(2):329-330
pubmed: 26851202
Peptides. 2006 Jul;27(7):1835-40
pubmed: 16621157
Blood Purif. 2014;37(4):304-10
pubmed: 25170751
Clin Biochem. 2004 Mar;37(3):210-6
pubmed: 14972643
Scand J Urol Nephrol. 2008;42(3):278-85
pubmed: 17943640
Transplant Direct. 2017 Jul 07;3(8):e190
pubmed: 28795142
Clin Biochem. 2018 Aug;58:72-77
pubmed: 29782819
Scand J Clin Lab Invest. 1972 Nov;30(3):271-4
pubmed: 4629674
Clin Endocrinol (Oxf). 1981 Sep;15(3):291-300
pubmed: 6273029
Am J Cardiol. 2016 Apr 15;117(8):1310-4
pubmed: 26916537
Acta Med Scand. 1970 May;187(5):419-28
pubmed: 5526960
Clin J Am Soc Nephrol. 2013 Feb;8(2):194-202
pubmed: 23124779
Scand J Clin Lab Invest. 1969 Jun;23(4):301-5
pubmed: 4986443
Clin Chem. 2007 Apr;53(4):766-72
pubmed: 17332152
Ann Intensive Care. 2017 Dec;7(1):49
pubmed: 28474317
J Am Soc Nephrol. 2017 Jan;28(1):291-303
pubmed: 27401687
Stat Methods Med Res. 1999 Jun;8(2):135-60
pubmed: 10501650
Acta Physiol (Oxf). 2017 Mar;219(3):554-572
pubmed: 27474473
Kidney Int. 2003 May;63(5):1944-7
pubmed: 12675875
Peptides. 2008 Jan;29(1):83-92
pubmed: 18082911
Clin Exp Pharmacol Physiol. 1995 Dec;22(12):891-902
pubmed: 8846510
Clin Kidney J. 2016 Oct;9(5):682-99
pubmed: 27679715
Am J Kidney Dis. 2016 Jan;67(1):49-55
pubmed: 26454686
Support Care Cancer. 2011 Oct;19(10):1527-32
pubmed: 20711842
Am J Cardiol. 2014 Jan 1;113(1):70-5
pubmed: 24176074
Nephron. 2017;136(4):302-308
pubmed: 28441651
Crit Care Med. 2008 Apr;36(4):1129-37
pubmed: 18379238
Clin Kidney J. 2016 Oct;9(5):700-4
pubmed: 27679716
Intensive Care Med. 2017 Sep;43(9):1198-1209
pubmed: 28138736
N Engl J Med. 1987 Oct 22;317(17):1098
pubmed: 3657876
Kidney Int. 2014 Mar;85(3):513-21
pubmed: 24107851
J Card Fail. 2017 Mar;23(3):231-239
pubmed: 27663098
Crit Care Med. 2001 Aug;29(8):1544-50
pubmed: 11505124